4.7 Article

Cardiac glycosides stimulate endocytosis of GLUT1 via intracellular Na+,K+-ATPase alpha 3-isoform in human cancer cells

Journal

JOURNAL OF CELLULAR PHYSIOLOGY
Volume 237, Issue 7, Pages 2980-2991

Publisher

WILEY
DOI: 10.1002/jcp.30762

Keywords

cancer; cardiac glycosides; endocytosis; glucose transporter; glycolysis; Na+; K+-ATPase

Funding

  1. Japan Society for the Promotion of Science
  2. Ministry of Education, Culture, Sports, Science and Technology of Japan [JP26460291, JP17K08531, 20K07258, JP16K08490, JP15K15029]
  3. Tamura Science & Technology Foundation
  4. Academic drug discovery support project commissioned by Toyama Prefecture
  5. Platform for drug discovery, informatics and structural life science
  6. Grants-in-Aid for Scientific Research [20K07258] Funding Source: KAKEN

Ask authors/readers for more resources

CGs can inhibit glucose metabolism of cancer cells by inhibiting Na+,K+-ATPase and decreasing the expression of GLUT1. The binding of CGs with intracellular alpha 3NaK elicits NAADP-mediated calcium mobilization.
Glucose transporter GLUT1 plays a primary role in the glucose metabolism of cancer cells. Here, we found that cardiac glycosides (CGs) such as ouabain, oleandrin, and digoxin, which are Na+,K+-ATPase inhibitors, decreased the GLUT1 expression in the plasma membrane of human cancer cells (liver cancer HepG2, colon cancer HT-29, gastric cancer MKN45, and oral cancer KB cells). The effective concentration of ouabain was lower than that for inhibiting the activity of Na+,K+-ATPase alpha 1-isoform (alpha 1NaK) in the plasma membrane. The CGs also inhibited [H-3]2-deoxy- d-glucose uptake, lactate secretion, and proliferation of the cancer cells. In intracellular vesicles of human cancer cells, Na+,K+-ATPase alpha 3-isoform (alpha 3NaK) is abnormally expressed. Here, a low concentration of ouabain inhibited the activity of alpha 3NaK. Knockdown of alpha 3NaK significantly inhibited the ouabain-decreased GLUT1 expression in HepG2 cells, while the alpha 1NaK knockdown did not. Consistent with the results in human cancer cells, CGs had no effect on GLUT1 expression in rat liver cancer dRLh-84 cells where alpha 3NaK was not endogenously expressed. Interestingly, CGs decreased GLUT expression in the dRLh-84 cells exogenously expressing alpha 3NaK. In HepG2 cells, alpha 3NaK was found to be colocalized with TPC1, a Ca2+-releasing channel activated by nicotinic acid adenine dinucleotide phosphate (NAADP). The CGs-decreased GLUT1 expression was significantly inhibited by a Ca2+ chelator, a Ca2+-ATPase inhibitor, and a NAADP antagonist. The GLUT1 decrease was also attenuated by inhibitors of dynamin and phosphatidylinositol-3 kinases (PI3Ks). In conclusion, the binding of CGs to intracellular alpha 3NaK elicits the NAADP-mediated Ca2+ mobilization followed by the dynamin-dependent GLUT1 endocytosis in human cancer cells.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available